CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Hedgepath Pharmaceuticals, Inc.  (HPPI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Hedgepath Pharmaceuticals's Quick Ratio

HPPI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

HPPI Quick Ratio (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Current Liabilities Change -46.76 % -33.3 % -13.1 % 49.77 % 30.74 %
Y / Y Cash & cash equivalent Change 2083.23 % 1086.38 % 185.85 % 143.72 % 41.3 %
Quick Ratio MRQ 6.54 23.16 7.57 7.47 0.16
Overall Ranking # 449 # 0 # 0 # 0 #
Seq. Current Liabilities Change 28.46 % -34.39 % -24.03 % -16.85 % 60.94 %
Seq. Cash & cash equivalent Change -63.7 % 100.78 % -23 % 3790.54 % -80.28 %



Quick Ratio first quarter 2017 Comment
Due to increase in Current Liabilities in the first quarter 2017, Quick Ratio fell to 6.54 below Hedgepath Pharmaceuticals, Inc. average.

Within Biotechnology & Drugs industry 49 other companies have achieved higher Quick Ratio than Hedgepath Pharmaceuticals in first quarter 2017. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are HPPI Segments?
See Quick Ratio HPPI on the trailing twelve month basis
Quick Ratio first quarter 2017 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 50
Healthcare Sector # 173
Overall Market # 449


Quick Ratio Statistics
High Average Low
23.16 3.97 0
(Dec 31 2016)   (Dec 31 2013)


You need to upgrade your Flash Player


Financial Statements
Hedgepath Pharmaceuticals's Current Liabilities $ 0 Millions Visit HPPI's Balance sheet
Hedgepath Pharmaceuticals's Cash & cash equivalent $ 3 Millions Visit HPPI's Balance sheet
Source of HPPI's Sales Visit HPPI's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2017, within Biotechnology & Drugs Industry Quick RatioMar 31 2017 MRQ Cash & cash equivalentMar 31 2017 MRQ Current Liabilities
Crispr Therapeutics Ag  17.08 $ 288.872  Millions$ 16.915  Millions
Cellular Biomedicine Group, Inc.  16.64 $ 33.362  Millions$ 2.006  Millions
Aerie Pharmaceuticals Inc  15.33 $ 207.864  Millions$ 13.562  Millions
Pulse Biosciences, Inc.  15.19 $ 18.860  Millions$ 1.242  Millions
Cadus Corp  14.87 $ 5.122  Millions$ 0.344  Millions
Voyager Therapeutics, Inc.  14.25 $ 157.670  Millions$ 11.064  Millions
Edge Therapeutics, Inc.  14.17 $ 95.591  Millions$ 6.746  Millions
Nantkwest, Inc.  13.45 $ 190.970  Millions$ 14.201  Millions
Cidara Therapeutics, Inc.  13.08 $ 90.086  Millions$ 6.886  Millions
Idera Pharmaceuticals, Inc.  13.02 $ 91.262  Millions$ 7.007  Millions
Asterias Biotherapeutics, Inc.  12.54 $ 32.500  Millions$ 2.592  Millions
Eiger Biopharmaceuticals, Inc.  11.97 $ 49.024  Millions$ 4.097  Millions
Protokinetix, Inc.  11.86 $ 0.549  Millions$ 0.046  Millions
Anavex Life Sciences Corp.  11.48 $ 23.352  Millions$ 2.034  Millions
Proteon Therapeutics Inc  11.29 $ 34.132  Millions$ 3.023  Millions
Cohbar, Inc.  11.06 $ 9.190  Millions$ 0.831  Millions
Brainstorm Cell Therapeutics Inc.  10.58 $ 8.347  Millions$ 0.789  Millions
Organovo Holdings, Inc.  10.44 $ 62.751  Millions$ 6.011  Millions
Intellia Therapeutics, Inc.  10.34 $ 257.551  Millions$ 24.910  Millions
Repligen Corp  10.32 $ 141.843  Millions$ 13.751  Millions
Adaptimmune Therapeutics Plc  10.15 $ 170.559  Millions$ 16.802  Millions
Kite Pharma, Inc.  10.10 $ 804.028  Millions$ 79.592  Millions
Neurocrine Biosciences Inc  10.00 $ 235.580  Millions$ 23.563  Millions
Sangamo Therapeutics, Inc  9.89 $ 129.266  Millions$ 13.064  Millions
Alder Biopharmaceuticals Inc  9.77 $ 289.564  Millions$ 29.635  Millions
Audentes Therapeutics, Inc.  9.49 $ 82.548  Millions$ 8.703  Millions
Atyr Pharma Inc  9.46 $ 61.934  Millions$ 6.549  Millions
Acceleron Pharma Inc  9.38 $ 142.509  Millions$ 15.193  Millions
Wave Life Sciences Ltd.  9.20 $ 129.484  Millions$ 14.070  Millions
Casi Pharmaceuticals, Inc.  9.08 $ 25.529  Millions$ 2.813  Millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
AEPP's Profile
Stock Price
AEPP's Financials
AEPP's Expectations
Business Description
Fundamentals
Charts & Quotes
AEPP's News
Suppliers
AEPP's Competitors
Customers & Markets
Economic Indicators
AEPP's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com